Highlights

  • Vaccine makers are working to adapt their shots to Omicron
  • Pfizer says it plans to ship new shot within next 100 days
  • New vaccine tailored for 'Omicron' likely by early next year: Moderna

Latest news

NIA to probe killing of chemist in Amravati in Maharashtra

NIA to probe killing of chemist in Amravati in Maharashtra

Vijay Deverakonda’s new ‘Liger’ look is breaking the internet and how!

Vijay Deverakonda’s new ‘Liger’ look is breaking the internet and how!

CJI Ramana: both govt and Opposition expect courts to take their side

CJI Ramana: both govt and Opposition expect courts to take their side

Udaipur tailor murder: Congress say one of the main accused is BJP member

Udaipur tailor murder: Congress say one of the main accused is BJP member

'Sita Ramam:' Dulquer Salmaan talks about shooting in Kashmir, says 'it's like stepping into a photograph

'Sita Ramam:' Dulquer Salmaan talks about shooting in Kashmir, says 'it's like stepping into a photograph

Will we need new vaccines for Omicron? Here's what vaccine makers say

Omicron scare: Scientists are still studying the virus, but vaccine makers are already at work to adapt their shots to the new variant

Will the present Covid-19 vaccines protect you against the Omicron variant of the virus that has created a global scare?

Well, scientists are studying the virus, but vaccine makers are already at work to adapt their shots to the virus that's considered to be highly infectious.

Pfizer, alongwith its partners BioNTech, plans to ship the new version of their shot within 100 days, Bloomberg has reported.

US-based vaccine maker Moderna expects a similar time-frame for a new vaccine tailored for 'Omicron'. It will possibly be available by early next year, Moderna's chief medical officer Paul Burton has told BBC.

Scientists, however, say they need more time to study the virus to come to any conclusion. There is still little clarity on its infectious nature, the severity of the disease it causes, and how well vaccines protect against it.

The World Health Organization said the overall risk from Omicron was "very high" and warned that any major surge would put pressure on health systems and cause more deaths.

Also Watch: Symptoms unfamiliar but mild: doctor who detected Omicron variant

Up Next

Will we need new vaccines for Omicron? Here's what vaccine makers say

Will we need new vaccines for Omicron? Here's what vaccine makers say

China's easing of quarantine period a glimmer towards easing of global isolation?

China's easing of quarantine period a glimmer towards easing of global isolation?

Covid vaccine Covovax gets nod for children aged 7-11 from Indian regulator: reports

Covid vaccine Covovax gets nod for children aged 7-11 from Indian regulator: reports

India tour of England: BCCI scold Team India players for roaming in public

India tour of England: BCCI scold Team India players for roaming in public

Covid vaccines prevented deaths of 42 lakh Indians in 2021: Lancet study

Covid vaccines prevented deaths of 42 lakh Indians in 2021: Lancet study

Long Covid in infected children can last at least two months: Lancet study

Long Covid in infected children can last at least two months: Lancet study

More videos

IND Vs ENG: R Ashwin tests positive for Covid-19, misses London flight

IND Vs ENG: R Ashwin tests positive for Covid-19, misses London flight

Bar suspected to be Covid-19 hotspot, new restrictions imposed in Beijing

Bar suspected to be Covid-19 hotspot, new restrictions imposed in Beijing

Anocovax: India's first Covid vaccine for animals launched

Anocovax: India's first Covid vaccine for animals launched

WHO: Covid-19 cases and deaths falling nearly everywhere

WHO: Covid-19 cases and deaths falling nearly everywhere

Not wearing masks? You can now be removed from the plane

Not wearing masks? You can now be removed from the plane

Maharashtra records 81% rise in daily Covid-19 cases

Maharashtra records 81% rise in daily Covid-19 cases

4-day work week? World's biggest trial begins in UK

4-day work week? World's biggest trial begins in UK

Biological E's Corbevax approved Covid-19 booster dose for 18 and above in India

Biological E's Corbevax approved Covid-19 booster dose for 18 and above in India

Congress President Sonia Gandhi tests positive for Covid-19, has mild fever

Congress President Sonia Gandhi tests positive for Covid-19, has mild fever

Is Covid-19 situation getting better in North Korea? This is what WHO said

Is Covid-19 situation getting better in North Korea? This is what WHO said

Editorji Technologies Pvt. Ltd. © 2022 All Rights Reserved.